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Abstract
Purpose To facilitate family doctor-driven follow-up for
adult childhood cancer survivors, we developed a survivor
care plan (SCP) for adult survivors and their family doctors.
Methods The SCP was accessible for survivors and their
family doctors on a secure website and as a printed booklet. It
included data on diagnosis, treatment and potential risks as
well as recommendations for follow-up. Childhood cancer
survivors who were off-treatment ≥5 years, aged ≥18 years
and not involved in a long-term follow-up program were
eligible. They were advised to visit their family doctor. The
endpoints were numbers of participants, adherence of family
doctors to the guidelines and satisfaction ratings.
Results The eligibility criteria were fulfilled by 108
survivors. Three family doctors and 15 survivors refused,
10 survivors were non-responders. Of the remaining 80
survivors, 73 survivors visited 72 family doctors. Sixty-
nine (96%) family doctors returned data of whom 60 (83%)
fully adhered to the recommended tests. The majority of
survivors and family doctors were satisfied about the SCP.
Conclusions A (web-based) SCP for survivors and family
doctors can serve as an effective communication vehicle to
provide adequate shared care by the long-term follow-up
clinic and family doctors.
Keywords Childhood cancer survivors . Survivor care
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Introduction
Survivors of childhood cancer are at risk of long-term
morbidity and have an increased risk of mortality. Two
thirds of long-term childhood cancer survivors have one or
more chronic health problems, while 40% have severe
problems, requiring medical surveillance or treatment [1–
3]. Whereas nowadays it is generally accepted that long-
term follow-up of these survivors is essential for detection
and treatment of late complications at an early stage, there
are still adult survivors from the past who do not yet
participate in long-term follow-up.
World-wide and recently also in The Netherlands,
guidelines have been developed to address the need for
long-term follow-up (www.survivorshipguidelines.org;
www.sign.ac.uk; www.ukccsg.org; www.skion.nl). Howev-
er, there is no consensus about the best way to organise this
follow-up care for adult long-term childhood cancer
survivors.
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Several models of long-term follow-up care have been
proposed [4–6]. Goldsby identified four models of long-
term follow-up care, namely a patient-driven, a primary
care provider-driven, a paediatric oncologist-driven and an
adult medicine-driven program. All these models have
advantages and disadvantages. Wallace et al. [6] suggested
that follow-up should be organised into three levels
according to a patient’s individual risk profile. Despite
these proposals, many adult survivors still have no regular
follow-up, receiving problem-driven medical care from
their family doctors [7]. Those being followed are predom-
inantly seen at paediatric oncology clinics, often even long
into adulthood. This policy cannot be sustained in the
future as the population of survivors increases and ages.
Moreover, paediatric oncologists are not the most appro-
priate health care providers for delivering care to adult
survivors. Transition to adult health care providers is
needed when the childhood cancer survivor reaches
adulthood. However, it is difficult to identify the best
possible health care worker to provide this follow-up care,
since the survivors may have ongoing complex health
needs and co-morbidities that require many different
approaches. A good alternative might be the family doctor.
In The Netherlands, almost everyone has health care access
through a national health plan and survivors usually have a
family doctor. Moreover, family doctors already have
cooperation with specialists in the shared care for other
complex health conditions, as diabetes, coronary artery
disease, heart failure and COPD. Lastly, the necessary tests
are no problem, since many medical tests, i.e. blood tests,
echocardiography, spirometry or bone density measure-
ment, can be requested by family doctors without the
intervention of a specialist.
For the transition from the paediatric oncologist to the
family doctor, the collaboration between the two profes-
sionals is essential, which might be guaranteed by a shared-
care model. This has been shown in adult cancer patients,
for whom several studies showed that they are willing to
consider follow-up by their family doctor as an alternative
to hospital-based care [8–10]. Moreover, in an earlier study,
we showed that shared care by paediatric oncologists and
family doctors is feasible for the follow-up of adult long-
term survivors [11]. Nearly 90% of the survivors and 80%
of the family doctors were satisfied with this shared-care
model. However, our previous study showed also that the
exchange of information between the long-term follow-up
clinics and the family doctors should be improved. A
survivor care plan (SCP) has been recommended for cancer
survivors to improve communication between the survivor,
the oncologist and the family doctor [12–17]. Survivors are
interested in a SCP; it has been shown that many patients
are interested in having access to their own medical record,
whether or not electronic [18].
Recently, Oeffinger et al. [19] studied the feasibility of a
mailed one-page SCP to promote risk-based screening
among high-risk Hodgkin lymphoma survivors who are
no longer followed at a cancer centre. They showed that the
self-reported rates of mammogram and echocardiogram
screening among high-risk survivors of childhood Hodgkin
lymphoma increased. Survivors were encouraged to discuss
the SCP with their family doctor.
We conducted a study on a SCPwith a family doctor-driven
design. We developed a personalised web-based SCP for
follow-up care, accessible for the adult survivors of childhood
cancer themselves as well as for their family doctors. We
studied the usefulness of this personalised SCP by evaluating
the adherence of family doctors to the guidelines, and
furthermore, we studied the experiences of survivors and
family doctors who used the (web-based) SCP for information.
Patients and methods
Participants
In the University Medical Centre Groningen (UMCG), care
for long-term childhood cancer survivors is provided by a
dedicated long-term follow-up clinic (LTFU), which was
initiated in 1995. Prior to the start of this LTFU clinic,
patients were usually discharged after a disease-free interval
of 5–10 years. Up to 2004, the total population of 5-year
non-CNS tumour survivors was 807 and 566 of them were
involved in regular follow-up. At that time, patients with
tumours of the central nervous system were being followed
by an independent multidisciplinary neuro-oncology team.
In 2004, we started to trace and recall the remaining 241
survivors who did not yet participate in any follow-up
program, as far as we knew. Patients with tumours of the
central nervous system, who were followed by a multidis-
ciplinary neuro-oncology team, were not eligible. Survivors
were traced with help of the municipal administration, and
if there were doubts if they were still alive, we contacted
their family doctor. In an earlier study in 2004, a random
sample of 133 of these survivors was recalled and 123
participated (10 lost to follow-up) in a shared-care follow-
up program with family doctors [11]. The present study
started in September 2008 and was designed for the benefit
of the remaining survivors, who also belonged to the group
of survivors who had been discharged before 1995 and who
had not been recalled to the long-term follow-up clinic yet.
Participants in the 2004 study were significantly younger at
the start of study compared with participants in the present
study (34 vs 38 years, p=0.007), and time since diagnosis
was significantly shorter (26 vs 29 years, p=0.015). There
were no significant differences in gender, age at diagnosis,
and initial diagnosis.
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Eligibility criteria of this study were: current age of
18 years or older, previous treatment for childhood cancer
at the Department of Paediatric Oncology of the UMCG,
The Netherlands, at least 5 years off-treatment, no mentally
handicapped and not yet being involved in any late effects
follow-up program elsewhere. No selection was made on
the base of the individual risk profile related to the
survivor’s cancer history.
Survivors were categorized in a three-level risk model on
the basis of their cancer history. According to Wallace et al.
[6], survivors at low-risk level (level 1) and medium-risk
survivors (level 2) could be managed in primary care, while
high-risk survivors (level 3) would need annual follow-up
in a late effects clinic. In our study, survivors of all three
levels were managed in primary care.
Procedure and development of a web-based survivor care
plan
Eligible survivors received an information letter about the
potential risks of late effects and the desirability of long-
term follow-up. Two weeks later, the possibility of follow-
up by the family doctor and details of the online SCP were
explained by telephone by a paediatric oncologist (AP) and
the survivor was invited to participate in this family doctor-
driven follow-up. If the survivor and his/her family doctor
agreed, we constructed a personalised SCP. This plan
consisted of detailed online information regarding the
patient’s cancer and treatment history, risks for potential
late effects, recommendations for future follow-up and
advice about a healthy lifestyle (based on the recently
developed Dutch DCOG LATER guidelines; www.skion.nl).
An example of a SCP is presented in Fig. 1.
This personalised SCP was made available on a secure
website to the survivors and to their family doctors, who
were provided by e-mail with a username and a password.
To the survivors, the SCP was also supplied as a printed
booklet.
Survivors were asked to make an appointment of at least
half an hour with their family doctor, and they were advised
to bring the printed SCP with them. After 6 months, an e-mail
reminder was sent to the survivors who had not yet planned a
late effects-related visit by their family doctor. Family doctors
were asked to return the results of the planned screening,
either by filling in the online form or the printed form
provided with a stamped addressed envelope. Written consent
for the web-based exchange of their medical data was
obtained from all participants.
To secure confidentiality, the personalised SCP did not
contain personal items such as names or addresses from the
survivors; instead, age in years and a serial number were
used for identification. As the study was meant to provide
recommended health care to survivors who were not yet
involved in any kind of follow-up and implementation of
the recently developed national guidelines for long-term
follow-up of childhood cancer survivors, the Ethics
Committee considered that no approval was required.
Late effects that were reported by the family doctors
were graded using the Common Terminology Criteria for
Adverse Events (version 4.0) [20]. Grade 1 effects are small
and usually asymptomatic. Grade 2 effects are moderate but
do not impair daily activities. Grade 3 effects are severe and
need more serious interventions. Grade 4 effects are
potentially life threatening.
Evaluation of the web-based survivor care plan
The SCP and the screening by the family doctor were
evaluated by using an 18-item questionnaire for the
survivors and a 14-item questionnaire for the family
doctors. The questionnaire included items on accessibility
and user friendliness of the website, and degree of
satisfaction with the provided information: in addition, the
survivors were asked whether negative memories were
triggered. Items could be answered on a four-point scale
(strongly agree, agree, disagree, strongly disagree), and
there was an option for ‘no opinion/not applicable’. For the
analysis, the answers were dichotomized to ‘agree’ or
‘disagree’.
Statistical analysis
Data were analysed by descriptive methods. No additional
statistical tests were performed. Descriptive analyses were
done with SPSS for Windows (version 15).
Results
Participants
Eighty of the 108 eligible survivors and 79 family doctors
(1 family doctor had 2 patients) participated. Ten survivors
were lost to follow-up, 3 family doctors refused and 15 of
the invited survivors refused to participate, mostly because
they felt healthy and did not wish to look back; they stated
that they had made a new start in life (Fig. 2). Five bone
tumour survivors were included who were over 18 years at
diagnosis and had been treated on paediatric oncology
protocols at the Department of Paediatric Oncology.
Characteristics of the participating survivors are shown in
Table 1. Within the first year of the study, 73/80 survivors
had visited 72 family doctors and 7 had not for various
reasons, such as moving abroad (n=1), serious medical
complications requiring specialist outpatient appointments
(n=4) and unknown (n=2). These seven patients did agree
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to complete a health questionnaire about their current health
status.
Evaluation of shared care including a web-based survivor
care plan
Data on the screening and additional test results were
returned by 69 of 72 (96%) family doctors who had seen a
survivor for screening. Eleven out of 72 (15%) family
doctors filled in the information in the online form, 61/72
(85%) family doctors used the printed form and returned
this in the provided stamped addressed envelope. Sixty
(83%) family doctors performed the screening according to
the Dutch guidelines, including laboratory tests, pulmonary
function tests and echocardiograms; nine family doctors did
not perform the complete battery of recommended tests.
According to the guidelines, 62 survivors needed laboratory
tests, 33 needed an echocardiogram, 16 needed a pulmo-
nary function test and 3 survivors needed a mammography.
Missing data included an echocardiogram (4 out of 33
patients who needed echocardiography according to the
guidelines), laboratory tests (4/62), mammography (1/3)
and a pulmonary function test (1/16).
Thirteen out of 80 survivors (16%) had no late effects,
whereas 48/80 (60%) had two or more late effects. Thirty-
four out of 80 (43%) had a severe grade 3 or 4 late effect.
Most frequent late effects of treatment included: psychoso-
cial problems (28/80, 35%), fertility issues (19/80, 24%),
Fig. 1 Example of two pages of
the website
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endocrine problems (16/80, 20%), cardiac problems (13/80,
16%), orthopaedic problems (13/80, 16%) and neurological
problems (13/80, 16%). Family doctors and survivors
merely reported the occurrence of a late effect and not
when it was detected; therefore, it is unknown how many of
these late effects were newly detected at the follow-up visit
and how many were already pre-existent. Eight survivors
(10%) had a second malignancy. Two of them had a
meningioma, one had an intracerebral cavernous haeman-
gioma, one had breast cancer, one had thyroid cancer, one
had gastric cancer, one had a basocellular carcinoma and
one had a meningioma as well as multiple basocellular
carcinomas.
Evaluation of the web-based survivor care plan
The survivors’ questionnaire was completed by 72/73
participating survivors (99%) (Table 2). The vast majority
(96%) had had access to the website and found the SCP
user-friendly for both the online and the printed version.
About three-quarters (73%) of them thought their knowledge
of late effects had improved through the SCP and nearly all
(97%) survivors had become more aware of the benefits of
follow-up. A minority of the survivors (11%) felt that the
provided information was insufficient. Typical comments
included ‘I lack information about psychological late
effects’, ‘I had expected more information’ and ‘The
language used in the survivorship care plan is too medical’.
Most survivors (82%) had confidence in the competence of
their family doctor to perform the screening. Only two had
‘The feeling that my family doctor doesn’t take me
seriously’, and one preferred ‘To have check-ups in the
late effects clinic and at the family doctor’s alternately’.
Many survivors (77%) had experienced reawakened mem-
ories of their past illness, and 34% stated that all the
supplied information had worried them.
The questionnaire for family doctors was completed by
53/72 participating family doctors (74%) (Table 3). Most
family doctors (85%) had had access to the website;
however, 15% of them experienced difficulties in entering
the website, mostly because they had forgotten their
password.
The vast majority of family doctors (97%) found the SCP
user-friendly; 83% felt that their knowledge of late effects and
95% that their awareness of the benefits of follow-up had
improved. Remarkably, 93% considered themselves capable
to perform follow-up care provided that a SCP was available.
One of the comments was ‘It helps to restore the contact with
patients who are cured of cancer’.
Discussion
This study shows that the availability of a web-based
personalised SCP facilitates optimal follow-up care in a
Present study 
 N = 108  
Lost to follow-up N = 10 
Invitation by telephone N = 98 
             Survivors included N = 80 
        Family doctors included N = 79 
Survivors refused N = 15 
Family doctors refused N = 3 
Survivors completed the study N= 73 
Family doctors completed the study N= 72 
Did not visit the family doctor N=7 
5- years survivors  treated at UMCG  
N=807 
(CNS excluded) 
No previous involvement in any 
 late effects program, N=241 
  Visited the LTFU clinic 
N=566 
Invited in study 2004 
N= 133 (123 participated) 
Fig. 2 Study profile
Table 1 Characteristics of included childhood cancer survivors (N=80)
Age in years (median, range)
At study 38 (19–56)
At diagnosis 9 (0–27)
Time since diagnosis 29 (11–44)
Type of tumour, number (%)
Leukaemia 31 (39)
Malignant lymphoma 8 (10)
Bone tumour 13 (16)
Soft tissue sarcoma 3 (4)
Wilms’ tumour 7 (9)




Cranial radiation 20 (25)
Chemotherapy 76 (95)
Bone marrow transplantation 5 (6)
Risk level (according to Wallace et al. [6])
Level 1 17 (21)
Level 2 19 (24)
Level 3 44 (55)
Outcome
Two or more late effects 48 (60)
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shared-care model between the late effect outpatient clinic
and family doctors. Moreover, the SCP was greatly
appreciated by the survivors, who had become more aware
of potential risks of health problems and of the benefits of
follow-up, as was concluded from the questionnaires.
Nearly all family doctors considered themselves capable
to perform follow-up care provided that a SCP was
available.
Participants were as satisfied with the web-based design as
with a written SCP. However, a web-based design has clear
advantages in favour of a written summary alone. Firstly, it is
accessible at any place or time, provided that an Internet
connection is available. Secondly, it ensures the availability of
the plan as patients change doctors. Moreover, it allows the
flexibility for additional data entry adapted to the individual
survivor’s needs and condition, and can easily be updated
upon new knowledge of late effects and/or renewed guidelines
for follow-up. In this way, the SCP can be kept up-to-date very
easily. Finally, a web-based SCP is unlikely to be lost
compared to a written version.
Other authors have advocated the use of a SCP [12–15,
17, 19, 21] in survivors of cancer and some advocate an
electronic version [12, 13]. In its report on care for adult
cancer survivors ‘From Cancer Patient to Cancer Survivor:
Lost in Transition’, the Institute of Medicine also strongly
recommended the provision of a SCP and considered it
necessary for ongoing clinical care of survivors [22]. It was
stated that a SCP might help patients share in the
responsibility for their health care and help to ensure
appropriate follow-up care. However, despite these recom-
mendations, reports on application of a SCP in survivors of
adult cancer are scarce. Miller et al. [16] reported a pilot
study on five breast cancer survivors and found that SCPs
provided practical guidance for survivors by organising the
requirements of follow-up and that is was helpful for
patient empowerment. Burg et al. [12] conducted four focus
group studies with breast cancer survivors who were asked
their opinions on the value and content of a survivorship
care plan. They concluded that among survivors, there was
general enthusiasm for the concept of a SCP. Similar
findings resulted from focus group studies performed by
Hewitt et al. [13] in survivors of various other types of
adult cancers. These survivors expressed a great interest in
having a personalised SCP presented in layman’s terms,
including attention to their psychological needs. Education-
al websites for survivors such as the new DCOG LATER
Table 2 Questionnaire responses from 72/73 participating survivors
Evaluation by survivors Agree Disagree No opinion 95% CI
Not applicable For agree
N % N % N %
About the website
Could enter the website 69 96 3 4 0 88–99
User-friendly 59 95 3 5 10 87–99
Information is clear 60 95 3 5 9 87–99
Information is sufficient 55 89 7 11 10 78–95
Information fulfils my needs 53 90 6 10 13 76–94
About the written survivorship care plan
User-friendly 66 97 2 3 4 90–>99
Information is clear 66 97 2 3 4 90–>99
Information is sufficient 58 84 11 16 3 73–92
Information fulfils my needs 60 90 7 10 5 80–96
About participation
My knowledge of late effects improved 47 73 17 27 8 61–84
Questions about the past were clarified 34 64 19 36 19 50–77
All this information worries me 22 34 43 66 7 23–47
Reminded me of past illness and experiences 55 77 16 23 1
Positive 15 27
Negative 11 20
Both positive and negative 29 53
From now on, I will return to my family doctor for late effects follow-up 50 82 11 18 11 70–91
More aware of the benefits of follow-up 65 97 2 3 5 90–97
I have confidence in my family doctor’s expertise in performing the screening 53 82 12 18 7 70–90
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patient information website (http://later.skion.nl) [23] and
templates for creation of a SCP on the Internet have been
developed by several groups [14, 24]. However, survivors
who want to create an individualized SCP by themselves,
for instance through Oncolife (http://www.oncolink.org/
oncolife), need detailed information on their cancer diag-
nosis and treatment. It can be questioned whether the
average survivor is aware of treatment details like names
and doses of cytostatic drugs, type, dose and field of
irradiation and surgery details. Also, it has been shown that
adult survivors of childhood cancer have significant
knowledge deficits regarding their disease and treatment
[25, 26]. If the data on which SCPs are created are strictly
based on user responses and not verified by a medical
professional, there is a considerable risk that the informa-
tion supplied will be incorrect or incomplete.
Oeffinger et al. [19] recently published a study that is
comparable with ours; however, there are some fundamental
differences. They also found that a mailed personalised
survivorship care plan was effective in communicating risk
and increasing compliance with recommended medical
surveillance among high-risk survivors of childhood Hodgkin
lymphoma. A fundamental difference between Oeffinger’s
study and ours is that in our study, the survivors could only
participate if they agreed to make an appointment at the
family doctor’s practice for a late effect-related visit, while in
the study of Oeffinger and colleagues, survivors were
encouraged to discuss the information from the SCP that
they had received by mail, with the family doctor. However,
only half of the participating survivors (29/55, 53%) actually
visited their family doctor, which is far less than the 73/80
(91 %) survivors in our study. In Oeffinger’s study, financial
restrictions could be a barrier for the survivors to visit the
family doctor for the recommended follow-up care, whereas
in The Netherlands, almost everyone has health care access
through a national health plan. Moreover, Dutch health
insurances refund the recommended follow-up screening.
Both Oeffinger’s study and ours show that when the
survivors presented the information to the family doctor, the
requested surveillance tests were ordered.
In contrast to the study of Oeffinger et al. [19], who
found no increase in anxiety following risk notification, in
our study 34% of the survivors stated that the provided
information had worried them. Negative consequences of
long-term follow-up have also been described before, such
as increased anxiety and being stigmatised as ‘a patient’, in
contrast to the benefits of follow-up, namely early detection
of late effects [27]. However, without information and
education of survivors, the quality of long-term follow-up
care may be suboptimal. The advantages and disadvantages
of long-term follow-up, including the provision of a SCP,
must be weighed carefully. In our study, 15% of eligible
survivors refused participation; a survey of their motives
would be worthwhile.
Table 3 Questionnaire responses from 53/72 participating family doctors
Evaluation by family doctors Agree Disagree No opinion 95% CI
Not applicable For agree
N % N % N %
About the website
Could enter the website 45 85 8 15 0 72–93
User-friendly 36 97 1 3 16 86–>99
Information is clear 39 100 0 0 14 91–100
Information is sufficient 39 100 0 0 14 91–100
Information fulfils my needs 37 100 0 0 16 91–100
About the written survivorship care plan
User-friendly 48 100 0 0 5 93–100
Information is clear 48 100 0 0 5 93–100
Information is sufficient 48 100 0 0 5 93–100
Information fulfils my needs 47 98 1 2 5 89–100
About participation
My knowledge of late effects improved 38 83 8 17 7 69–92
Do you think memories of past illness and experiences were recalled by your patient? Yes, 27 63 No, 16 37 10
Positive 0 0
Negative 8 20
Both positive and negative 19 43
More aware of the benefits of follow-up 42 95 2 5 9 85–99
Able to perform follow-up care if a survivorship care plan is available 41 93 3 7 9 81–99
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Other barriers for SCPs exist, such as preparation time
involved for busy clinicians as well as lack of research
related to care plans and patient outcomes [15, 16]. In our
study, the creation of the SCP required hardly any
preparation time as data on diagnosis, treatment and
potential risks could be retrieved from the database register
automatically. However, the availability of a complete and
up-to-date database remains a prerequisite. In addition, the
availability of recently completed Dutch national guidelines
for the long-term follow-up of childhood cancer survivors
enabled us to add personalised recommendations for
follow-up and healthy lifestyle.
The questionnaire responses showed that the vast
majority of the participating family doctors in our study
considered themselves competent to participate in the
care of long-term childhood cancer survivors, if a SCP
is made available. This is supported by the results of
patient encounters, as 83% of the family doctors had
completed the recommended tests as included in the
SCP and had returned the results to the late effects
clinic. These results are the more remarkable given that
55% of CCS were categorized as level 3 patients with a
high risk of developing serious late effects, who,
according to Wallace et al. [6], should have been in
annual follow-up from a medically supervised late effects
clinic. Level 3 survivors benefit less from follow-up by
primary care providers because they often require referral
to a specialist for additional tests such as pulmonary
function tests or echocardiography. Most family doctors
stated that their knowledge of the survivor’s health status
had improved as well as their knowledge of late effects.
This is an important achievement, as it makes family
doctors aware of a possible relation with the cancer history
if a survivor seeks medical help. This could be particularly
beneficial for level 3 patients with a high risk for complex
health problems.
Until now, in our study, a key role was allotted to an
academic family doctor (RB) with an interest in late effects
of treatment. This family doctor is fully aware of current
general practice, its possibilities and its limitations. Once
the piloting stage has been finished, this role probably
could be taken over by a dedicated oncology nurse or nurse
practitioner.
Although the majority of survivors greatly appreciated
the SCP, 1 out of 10 was not satisfied, commenting that the
language used in the SCP was too technical and that the
information did not meet their expectations, particularly
regarding psychosocial issues. These issues must be
addressed in a subsequent version of the SCP.
A limitation of our study is that the number of
participants is rather small. The questionnaires that were
used for the evaluation were anonymous, as we expected
that anonymity would increase the response rate. Because
of this anonymity, it was not possible to compare
satisfaction rates between the three risk groups. Another
matter of concern is the fact that 15% of the participating
family doctors stated that they could not enter the website,
mostly because they had forgotten the password and only
15% of the family doctors filled in the information in the
online screening form. Therefore, besides the possibility to
exchange information online, there is still a need to use a
printed version of the SCP and screening forms with a
stamped addressed envelope.
We conclude that a web-based SCP can serve as an
effective communication vehicle between the survivor, the
family doctor and the long-term outpatient clinic to provide
follow-up care by family doctors.
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